Clinical Trial Update: Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating genistein, gemcitabine, and erlotinib for locally advanced or metastatic pancreatic cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)
• Genistein (genistein)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-26